TBPH NASDAQ
Theravance Biopharma Inc
1W: +0.1%
1M: +0.0%
3M: -3.4%
YTD: -6.2%
1Y: +21.2%
3Y: +88.0%
5Y: +139.5%
$17.03
Last traded 2026-09-25 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships9
As Filer
counterparties named
1
As Counterparty
mentioned by others
3
Rel. Types
2021-06-28
Earliest Filing
2025-06-02
Latest Filing
partner: 6
acquirer: 2
investor: 1
Counterparties (Filed by TBPH)
9 relationshipsCompanies named in TBPH's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| GlaxoSmithKline Intellectual Property Development Limited | — | acquirer | TBPH assigned royalty interests to GSK in exchange for $225 million | 2025-06-02 | View |
| Glaxo Group Limited | — | acquirer | GSK entity involved in the royalty assignment agreement | 2025-06-02 | View |
| Royalty Pharma Investments 2019 ICAV | RPRX | investor | Previous buyer of TBPH's interests in Theravance Respiratory Company, LLC | 2025-06-02 | View |
| Irenic Capital Management LP | — | partner | Entered into a cooperation agreement regarding board appointment and information sharing | 2023-12-21 | View |
| Irenic Capital Management GP LLC | — | partner | Entered into a cooperation agreement regarding board appointment and information sharing | 2023-12-21 | View |
| Irenic Capital Evergreen Master Fund LP | — | partner | Entered into a cooperation agreement regarding board appointment and information sharing | 2023-12-21 | View |
| Irenic Capital Evergreen Fund GP LLC | — | partner | Entered into a cooperation agreement regarding board appointment and information sharing | 2023-12-21 | View |
| SVB Leerink LLC | — | partner | Underwriter representative in public offering | 2021-06-28 | View |
| Evercore Group L.L.C. | EVR | partner | Underwriter representative in public offering | 2021-06-28 | View |
Mentioned As Counterparty
1 mentionsOther companies that named TBPH in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-23 | Material Agreement; Acquisition/Disposition; Delisting Notice; Change in Control; Officer/Director C | Agreement Acquisition | View |
| 2026-09-18 | Shareholder Vote | View | |
| 2026-09-10 | Other Events | View | |
| 2026-08-25 | Other Events; Exhibits | View | |
| 2026-08-10 | Earnings Release; Exhibits | View | |
| 2026-06-29 | Material Agreement; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2026-06-23 | Officer/Director Change | View | |
| 2026-06-12 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-30 | Other Events | View | |
| 2026-03-03 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Re | View | |
| 2026-01-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-08 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-25 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-20 | Other Events | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-26 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-06 | Other Events | View | |
| 2025-06-02 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Regula | Agreement Acquisition | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR